| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Betahistine Treatment Improves the Recovery of Static Symptoms in Patients With Unilateral Vestibular Loss
|
Redon, Christine
|
|
2011
|
51 |
4 |
p. 538-548
|
article
|
| 2 |
Clonidine Clearance Matures Rapidly During the Early Postnatal Period: A Population Pharmacokinetic Analysis in Newborns With Neonatal Abstinence Syndrome
|
Xie, Hong-Guang
|
|
2011
|
51 |
4 |
p. 502-511
|
article
|
| 3 |
Differences Between Japan and the United States in Dosages of Drugs Recently Approved in Japan
|
Nakashima, Kae
|
|
2011
|
51 |
4 |
p. 549-560
|
article
|
| 4 |
Do Drug Transporter (ABCB1) SNPs Influence Cyclosporine and Tacrolimus Dose Requirements and Renal Allograft Outcome in the Posttransplantation Period?
|
Singh, Ranjana
|
|
2011
|
51 |
4 |
p. 603-615
|
article
|
| 5 |
Effect of Steady-State Enoxacin on Single-Dose Pharmacokinetics of Roflumilast and Roflumilast N-Oxide
|
Lahu, Gezim
|
|
2011
|
51 |
4 |
p. 586-593
|
article
|
| 6 |
Effects of Commonly Administered Agents and Genetics on Nebivolol Pharmacokinetics: Drug—Drug Interaction Studies
|
Lindamood, Charles
|
|
2011
|
51 |
4 |
p. 575-585
|
article
|
| 7 |
Human Breast Milk as a Source of DNA for Amplification
|
Haas, David M.
|
|
2011
|
51 |
4 |
p. 616-619
|
article
|
| 8 |
No Dose Adjustment on Coadministration of the PDE4 Inhibitor Roflumilast With a Weak CYP3A, CYP1A2, and CYP2C19 Inhibitor: An Investigation Using Cimetidine
|
Böhmer, Gabriele M.
|
|
2011
|
51 |
4 |
p. 594-602
|
article
|
| 9 |
Pharmacokinetic-Pharmacodynamic Modeling of Apratastat: A Population-Based Approach
|
Shu, Cathye
|
|
2011
|
51 |
4 |
p. 472-481
|
article
|
| 10 |
Pharmacokinetics, Safety, and Tolerability Following Multiple Oral Doses of Varenicline Under Various Titration Schedules in Elderly Nonsmokers
|
Qinying Zhao,
|
|
2011
|
51 |
4 |
p. 492-501
|
article
|
| 11 |
Population Pharmacokinetics and Pharmacodynamics of Brief Etomidate Infusion in Healthy Volunteers
|
Kaneda, Kotaro
|
|
2011
|
51 |
4 |
p. 482-491
|
article
|
| 12 |
Review: Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials
|
Karsdal, M.A.
|
|
2011
|
51 |
4 |
p. 460-471
|
article
|
| 13 |
Single- and Multiple-Dose Pharmacokinetics of the Selective Nicotinic Receptor Partial Agonist, Varenicline, in Healthy Japanese Adult Smokers
|
Kikkawa, H.
|
|
2011
|
51 |
4 |
p. 527-537
|
article
|
| 14 |
Single- and Multiple-Dose Pharmacokinetics, Safety, and Tolerability of the Selective α7 Neuronal Nicotinic Receptor Agonist, ABT-107, in Healthy Human Volunteers
|
Othman, Ahmed A.
|
|
2011
|
51 |
4 |
p. 512-526
|
article
|
| 15 |
Tecarfarin, a Novel Vitamin K Reductase Antagonist, Is Not Affected by CYP2C9 and CYP3A4 Inhibition Following Concomitant Administration of Fluconazole in Healthy Participants
|
Bavisotto, Linda M.
|
|
2011
|
51 |
4 |
p. 561-574
|
article
|
Journal description